Drug & supplement interaction

Atractylodes + Risankizumab-Rzaa

Risankizumab-Rzaa brand name: Skyrizi.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Atractylodes and Risankizumab-Rzaa in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first. Additionally, although there is no interaction, the two are separately associated with some of the same side effects, which would make a new symptom harder to attribute to one or the other.

Know someone taking this? Share
Interaction report

Atractylodes and Risankizumab-Rzaa

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Risankizumab-Rzaa and Atractylodes in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Atractylodes safety at a glance

Atractylodes overall Use caution Often used traditionally, but human safety data are limited, so use cautiously and under guidance.
Pregnancy Possibly Unsafe When used orally. In animals, atractylodes has caused reproductive toxicity, including fetal death, as well as changes in gestation, growth, and skeletal format... Read the full pregnancy detail
Breastfeeding Avoid Safety while breastfeeding is unknown, so avoid it to be safe.

Pregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center) — the full detail is in the Special populations card below. Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Risankizumab-Rzaa and Atractylodes? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
How we checked

Why No Interaction Is Listed for Risankizumab-Rzaa

Interactions in our licensed database are recorded against drug classes, not just single drug names. Risankizumab-Rzaa is filed under a single classification — immunosuppressants. Atractylodes has documented interactions with 5 drug classes — the most serious being anticoagulant/antiplatelet drugs (moderate), aromatase inhibitors (moderate) and hexobarbital (moderate) — and none of Risankizumab-Rzaa’s classifications are among them.

Classification data comes from our licensed Natural Medicines dataset. A medication can belong to classes beyond those recorded there, so this describes how the check was run — it is not a safety guarantee.

Keep it in perspective

Atractylodes Does Interact With Other Medications

Atractylodes has 127 moderate, 674 minor known drug interactions in our database — Risankizumab-Rzaa isn’t one of them. If you take anything else, check it against the full list below.

Taking anything else?

Check Another of Your Medications Against Atractylodes

Covers the 2,830 medications we’ve checked against Atractylodes. Pick one to open its full report.

What to actually watch for

No Interaction Found — But Data Suggests Atractylodes and Risankizumab-Rzaa May Share a Side Effect

This is not an interaction. Neither one changes how your body handles the other, and nothing here says they react together. What our sources do show is that each has separately been linked to the effects below — so taking both can make those effects more likely to turn up, and harder to pin on one or the other if they do. One of them is worth acting on rather than waiting out — marked below.

  • An allergic reaction Worth acting on Additional detail

    Atractylodes

    “There is currently a limited amount of information on the adverse effects of atractylodes. A thorough evaluation of safety outcomes has not been conducted.

    Most Common Adverse Effects:

    Orally: Allergic reaction, dry mouth, nausea.”

    Atractylodes · Natural Medicines adverse-effect record, reported in dry mouth.

    Risankizumab-Rzaa

    Listed in the ADVERSE REACTIONS section of the FDA label for Risankizumab-Rzaa. Read the label on DailyMed ›

Reported for Atractylodes but not commonly for Risankizumab-Rzaa: dry mouth and nausea.

Effects for Risankizumab-Rzaa come from the ADVERSE REACTIONS section of its FDA label; effects for Atractylodes come from the Natural Medicines adverse-effect record, quoted above. Wording is matched across sources by our own clinical vocabulary, so treat this as a prompt to pay attention, not a diagnosis.

Special populations

Atractylodes in Pregnancy & Breastfeeding

Pregnancy Possibly Unsafe

When used orally. In animals, atractylodes has caused reproductive toxicity, including fetal death, as well as changes in gestation, growth, and skeletal formation.

DISCLAIMER: This tool is intended for informational purposes only, and should not be interpreted as specific medical advice. Patients should consult with a qualified healthcare provider before making decisions about therapies and/or health conditions.© 2026 Therapeutic Research Center

Overlapping uses

What Risankizumab-Rzaa Is Prescribed For, and What Atractylodes Has Been Studied For

These two come up together because they touch the same health topic — not because they do the same job. Risankizumab-Rzaa is a prescription medicine with approved uses on its FDA label. Atractylodes is a supplement: what follows is what researchers have looked at it for, and how strong that evidence is.

Risankizumab-Rzaa is prescribed for: Skyrizi (risankizumab-rzaa) injection is approved to treat moderate-to-severe plaque psoriasis and active psoriatic arthritis in adults and children 6 years of age and older. It is also approved for moderately to severely active Crohn's disease and moderately to severely active ulcerative colitis in adults. For plaque psoriasis and psoriatic arthritis, Skyrizi is given as a subcutaneous (under-the-skin) injection. For Crohn's disease and ulcerative colitis, Skyrizi treatment begins with intravenous (IV) infusions given in a clinical setting, followed by subcutaneous maintenance injections.

Atractylodes has been studied for:

  • Diarrhea studied, not established Atractylodes has been studied for this. Natural Medicines rates the evidence: Insufficient Reliable Evidence To Rate Read what the research shows

    Atractylodes for diarrhea

    Although there has been interest in using oral atractylodes for diarrhea, there is insufficient reliable information about the clinical effects of atractylodes for this purpose.

Effectiveness ratings and the research summaries above are the verbatim record from the Natural Medicines database, which grades evidence from “Effective” down to “Insufficient Reliable Evidence To Rate”. A rating below the top of that scale means researchers have looked at it — not that it works, and never that it can stand in for a prescribed medicine. Do not stop or replace Risankizumab-Rzaa on your own; if you are taking Atractylodes for the same health topic, tell your prescriber, especially if the medicine is being adjusted to a target.

Everything else you take

See Every Supplement That Interacts With Risankizumab-Rzaa

This page covers Atractylodes only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Risankizumab-Rzaa page lists 53 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Active Hexose Correlated Compound (ahcc) (moderate), Alfalfa (moderate), American Ginseng (moderate), Andrographis (moderate) and Ashwagandha (moderate).

By severity: 52 moderate · 1 minor.

From our pharmacist’s overview on the Risankizumab-Rzaa page

“Echinacea captures the concern on this page better than any other entry. Risankizumab-rzaa (Skyrizi) treats plaque psoriasis, psoriatic arthritis, and Crohn's disease by quieting one arm of the immune system, and echinacea, like nearly all 53 ingredients listed here, is taken specifically to stir the immune system up.”

Reviewed by 2 · Jul 18, 2026

Open the Risankizumab-Rzaa interaction page

One more smart check

Taking Atractylodes as Part of a Dietary Supplement Product? Check It for Interactions

We hold 691 real supplement products containing Atractylodes, each one broken down to its full ingredient list — and combination products often carry several ingredients besides Atractylodes. Even though Atractylodes itself has no known interaction with Risankizumab-Rzaa, another ingredient on your label might. Find your product and we’ll check every ingredient on its label:

How much people look this up

Where Atractylodes and Risankizumab-Rzaa Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Atractylodes
Top 25%

#249 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Risankizumab-Rzaa
Steady interest

#1,963 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions.
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Atractylodes reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Atractylodes and Risankizumab-Rzaa records this page draws on were last updated July 11, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Atractylodes

What is Atractylodes?

Atractylodes
  • Digestive upset and poor appetite
  • Bloating and fluid retention
  • General fatigue or 'weakness'
  • Diarrhea
  • Support within traditional formulas

Atractylodes is a root used for centuries in traditional Chinese, Japanese, and Thai medicine, mostly for digestive complaints and fatigue, often as part of multi-herb formulas. Modern research is still early and mostly from lab and animal studies, so its true benefits in people are not well proven. If you want to try it, talk with a pharmacist or doctor first, and avoid it during pregnancy and breastfeeding.

Atractylodes macrocephala; Atractylodes lancea · Asteraceae · Rhizome (root) · Dried root, powders, capsules, decoctions (teas), and part of traditional Chinese and Japanese herbal formulas

An interaction check asks whether these two react with each other — it does not ask whether Atractylodes is a good idea for someone in your situation. Here is what our Atractylodes record says about it on its own.

Atractylodes: dosing

There is no well-established standard dose for Atractylodes as a single supplement, and traditional amounts vary depending on the formula and the form used (dried root, powder, capsule, or decoction).If you choose to use it, follow the directions on the product label and do not exceed the suggested amount.

From our Atractylodes monograph — the full record covers uses, side effects and every documented interaction.

Read the full Atractylodes monograph & all interactions
Medication

About Risankizumab-rzaa Injection

What Is Risankizumab-rzaa Injection Used For?

Brand name: Skyrizi

Skyrizi (risankizumab-rzaa) injection is approved to treat moderate-to-severe plaque psoriasis and active psoriatic arthritis in adults and children 6 years of age and older. It is also approved for moderately to severely active Crohn's disease and moderately to severely active ulcerative colitis in adults.

For plaque psoriasis and psoriatic arthritis, Skyrizi is given as a subcutaneous (under-the-skin) injection. For Crohn's disease and ulcerative colitis, Skyrizi treatment begins with intravenous (IV) infusions given in a clinical setting, followed by subcutaneous maintenance injections.

See full Risankizumab-rzaa Injection drug information
Keep checking

Other Drugs & Atractylodes

Browse every other medication we’ve checked against Atractylodes — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
127Moderate
674Minor
2,028No known interaction
Moderate

127 interactions

Showing 60 of 127 moderate interactions — see all 127 on the Atractylodes page.

Minor

674 interactions

Showing 60 of 674 minor interactions — see all 674 on the Atractylodes page.

No interaction 2,028 drugs checked — show the list
Evidence & sources

Atractylodes References

The 6 references that drive our Atractylodes monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.

  1. Liu Y, Jia Z, Dong L, et al. A randomized pilot study of atractylenolide I on gastric cancer cachexia patients. Evid Based Complement Alternat Med 2008;5:337-44. PubMed
  2. Chen Y, Yang W, Guo L, Wu X, Zhang T, Liu J, Zhang J. Atractylodes lactone compounds inhibit platelet activation. Platelets. 2017 Mar;28(2):194-202. PubMed
  3. Jiang H, Shi J, Li Y. Screening for compounds with aromatase inhibiting activities from Atractylodes macrocephala Koidz. Molecules. 2011 Apr 14;16(4):3146-51. PubMed
  4. Koonrungsesomboon N, Na-Bangchang K, Karbwang J. Therapeutic potential and pharmacological activities of Atractylodes lancea (Thunb.) DC. Asian Pac J Trop Med. 2014 Jun;7(6):421-8. PubMed
  5. Li L, Tang LY, Man GC, Yeung BH, Lau CB, Leung PC, Wang CC. Potential reproductive toxicity of Largehead Atractylodes Rhizome, the most commonly used Chinese medicine for threatened miscarriage. Hum Reprod. 2011 Dec;26(12):3280-8. PubMed
  6. Muhamad N, Plengsuriyakarn T, Na-Bangchang K. Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice. PLoS One 2022;17(11):e0277614. PubMed

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Atractylodes and Risankizumab-Rzaa Together: Common Questions

Is it safe to take Atractylodes with Risankizumab-Rzaa?
We do not list a known interaction between Atractylodes and Risankizumab-Rzaa. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Do Atractylodes and Risankizumab-Rzaa have any of the same side effects?
Yes — our sources link each of them separately to one of the same effects. That is not an interaction: neither changes how your body handles the other. It does mean that if one of those effects turns up, it can be harder to tell which one is behind it. They are listed on this page with the source behind each.
Are Atractylodes and Risankizumab-Rzaa used for the same thing?
They overlap in purpose, which usually means the real question is whether you need both rather than whether they are safe together. This page lists the shared uses and how strong the evidence is for Atractylodes in each. That is a conversation for your prescriber, especially if Risankizumab-Rzaa is being adjusted to a target.
How was the Atractylodes and Risankizumab-Rzaa combination checked?
Interactions in our licensed database are recorded against drug classes. Risankizumab-Rzaa is filed under 1 classification, and Atractylodes has documented interactions with 5 drug classes — none of Risankizumab-Rzaa's classifications are among them. A medication can belong to classes beyond those recorded in our dataset, so this describes how the check was run rather than guaranteeing safety.
Does Atractylodes interact with any other medications?
Yes. Atractylodes has 801 documented drug interactions in our database — Risankizumab-Rzaa is simply not one of them. If you take anything else, it is worth checking each one; they are all listed on this page.
Does Risankizumab-Rzaa interact with any supplements?
Yes. Risankizumab-Rzaa has documented interactions with 53 supplements in our database — Atractylodes is not one of them. The Risankizumab-Rzaa interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Risankizumab-Rzaa and Atractylodes?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.